Long term outcome in chronic thromboembolic pulmonary hypertension in the multimodality treatment era: a UK national cohort analysis - Milan 2023

Novelties in pulmonary hypertension management

Chair(s): Marc Humbert, Esther Jeritza Nossent

Session type: Oral presentation

Long term outcome in chronic thromboembolic pulmonary hypertension in the multimodality treatment era: a UK national cohort analysis

Paula Appenzeller

EVENTS HOME

Previous presentation

Next presentation

Session content

Late Breaking Abstract - A long-term follow-up (LTFU) study of sotatercept for pulmonary arterial hypertension (PAH)

Ioana R Preston

Replay

Poster

Abstract

Slides

Population health model predicting the long-term impact of sotatercept on morbidity and mortality in patients with Pulmonary Arterial Hypertension (PAH)

Vallerie Mclaughlin

Replay

Poster

Abstract

Slides

Long term outcome in chronic thromboembolic pulmonary hypertension in the multimodality treatment era: a UK national cohort analysis

Paula Appenzeller

Replay

Poster

Abstract

Slides

Seralutinib improves pulmonary arterial blood vessel volume distribution in pulmonary arterial hypertension (PAH): results of the TORREY phase 2 imaging substudy

Roham Zamanian

Replay

Poster

Abstract

Slides

External validation of the European cardiac magnetic resonance risk stratification in the Amsterdam UMC PAH patient cohort

Lucas Celant

Replay

Poster

Abstract

Slides

Subtypes of pulmonary hypertension: gas uptake to lung capillaries and lung microstructure assessed by 129Xe MRI

Agilo Luitger Kern

Replay

Poster

Abstract

Slides

Prediction of revised pumonary hypertension hemodynamic thresholds using 4D flow MRI

Deepa Gopalan

Replay

Poster

Abstract

Slides

Comparison of risk stratification models for prediction of mortality in SSc-PAH in EUSTAR

Hilde Jenssen Bjorkekjaer

Replay

Poster

Abstract

Slides

Long-term outcome of patients with combined post- and precapillary pulmonary hypertension

Anna Titz

Replay

Poster

Abstract

Slides

Altitude related adverse effect and therapeutic benefit of supplemental oxygen in patients with pulmonary vascular disease during an overnight stay at 2500m

Simon Raphael Schneider

Replay

Abstract

Slides

Discussion and Q&A

Replay

CDN Connection Issue

The ERS International Congress 2023, Milan

#{title}